Follicular Fluid-Specific Distribution of Vascular Endothelial Growth Factor Isoforms and sFlt-1 in Patients Undergoing IVF and Their Correlation With Treatment Outcomes

Abstract

Objective: To investigate the distribution of vascular endothelial growth factor (VEGF) isoforms and soluble form of VEGF receptor 1 (sFlt-1) in the follicular fluid (FF) of in vitro fertilization (IVF) patients in relationship to age, body mass index (BMI), diagnosis of polycystic ovary syndrome (PCOS), and their correlation with IVF outcomes. Design: Prospective study. Main Outcome Measures: VEGF₁₂₁ and VEGF₁₆₅ isoforms were detected using Western blotting and pixel density analysis. The concentration of sFlt-1 was determined by enzyme-linked immunosorbent assay (ELISA). In vitro fertilization outcomes measured included number of oocytes retrieved, fertilization rate, and clinical pregnancy. Statistical analysis used the Kruskal-Wallis and Mann-Whitney U test where appropriate. Results: There was a statistically significant association between higher VEGF₁₆₅ levels and the diagnosis of PCOS, BMI ≥ 30, and age ≥40 years. In vitro fertilization cycles resulting in pregnancy were linked to statistically lower VEGF₁₆₅ levels in the FF. No statistically significant trend was identified in levels of VEGF₁₂₁ or sFlt-1 relative to patient characteristics or IVF outcomes. Conclusion: Our results suggest that elevated VEGF₁₆₅ levels are associated with less favorable patient characteristics and clinical IVF outcomes.

Keywords

VEGF isoforms VEGFR-1 (sFlt-1)follicular fluid IVF outcomes

Get full access to this article

View all access options for this article.

References

Ferrara N. , Houck K. , Jakeman L. , Leung DW Molecular and biological properties of the vascular endothelial growth factor family of polypeptides. Endocr Rev. 1992;13(1):18-32.

Leung DW , Cachianes G. , Kuang WJ , Goeddel DV , Ferrara N. Vascular endothelial growth factor is a secreted angiogenic mitogen . Science. 1989;246(4935):1306-1309.

Qui Y. , Hoareau-Aveilla C. , Oltean S. , Harper SJ , Bates DO The anti-angiogenic isoforms of VEGF in health and disease. Biochem Soc Trans. 2009;37(pt 6):1207-1213.

Guo P. , Xu L. , Pan S. , et al. Vascular endothelil growth factor isoforms display distinct activities in promoting tumor angiogenesis at different anatomic sites. Cancer Res. 2001;61(23):8569-8577.

Keyt BA , Berleau LT , Nguyen HV , et al. The carboxyl-terminal domain (111-165) of vascular endothelial growth factor is critical for its mitogenic potency. J Biol Chem. 1996;271(13):7788-7795.

Shibuya M. , Yamaguchi S. , Yamane A. , et al. Nucleotide sequence and expression of a novel human receptor-type tyrosine kinase gene (flt) closely related to the fms family. Oncogene. 1990;5(4):519-524.

Kendall RL , Thomas KA Inhibition of vascular endothelial growth factor activity by an endogenously encoded soluble receptor. Proc Nat Acad Sci U S A. 1993;90(22):10705-10709.

Kendall RL , Wang G. , Thomas KA Identification of a natural soluble form of the vascular endothelial growth factor receptor, FLT-1, and its heterodimerization with KDR. Biochem Biophys Res Commun. 1996;226(2):324-338.

Sengupta J. , Lalitkumar PG , Najwa AR , et al. Immunoneutralization of vascular endothelial growth factor inhibits pregnancy establishment in the rhesus monkey (Macaca mulatta). Reproduction. 2007;133(6):1199-1211.

10.

Regnault TRH , Orbus RJ , De Vrijer B. , et al. Placental expression of VEGF, PlGF and their receptors in a model of placental insufficiency-intrauterine growth restriction (PI-IUGR). Placenta. 2002 ;23(2-3):132-144.

11.

Vuorela P. , Carpén O. , Tulppala M. , Halmesmäki E. VEGF, its receptors and the tie receptors in recurrent miscarriage . Mol Hum Reprod. 2000;6(3):276-282.

12.

Maynard SE , Min JY , Merchan J. , et al. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest. 2003;111(5):649-658.

13.

Levine RJ , Maynard SE , Qian C. , et al. Circulating angiogenic factors and the risk of preeclampsia . N Engl J Med. 2004;350(7): 672-683.

14.

Lee A. , Christenson LK , Patton PE , Burry KA , Stoufer RL Vascular endothelial growth factor production by human luteinized granulosa cells in vivo. Hum Reprod. 1997;12(12):2756-2761.

15.

Kamat BR , Brown LF , Manseau EJ , Senger DR , Dvorak HF Expression of vascular permeability factor/vascular endothelial growth factor by human granulose and theca lutein cells. Role in corpus luteum development. Am J Pathol. 1995;146(1): 157-165.

16.

Laitinen M. , Ristimaki A. , Honkasalo M. , Narko K. , Paavonen K. , Ritvos O. Differential hormonal regulation of vascular endothelial growth factors VEGF, VEGF-B, and VEGF-C messenger ribonucleic acid levels in cultured human granulosa-luteal cells. Endocrinology. 1997;138(11):4748-4756.

17.

Ferrara N. , Davis-Smyth T. The biology of vascular endothelial growth factor. Endocr Rev. 1997;18(1):14-25.

18.

Van Blerkom J. , Antczak M. , Schrader R. The development potential of the human oocyte is related to the dissolved oxygen content of follicular fluid: association with vascular endothelial growth factor levels and perifollicular blood flow characteristics. Hum Reprod. 1997 ;12(5):1047-1055.

19.

Fujimoto J. , Sakaguchi H. , Hirose R. , Ichigo S. , Tamaya T. Biologic implications of the expression of vascular endothelial growth factor subtypes in ovarian carcinoma. Cancer. 1998;83(12):2528-2533.

20.

Otani N. , Minami S. , Yamoto M. , et al. The vascular endothelial growth factor/fms-like tyrosine kinase system in human ovary during the menstrual cycle and early pregnancy. J Clin Endocrynol Metab. 1999;84(10):3845-3851.

21.

Pepper MS , Ferrara N. , Orci L. , Montesano R. Vascular endothelial growth factor (VEGF) induces plasminogen activator inhibitor-1 in microvascular endothelial cells. Biochem Biophys Res Commun . 1991;181(2):902-906.

22.

Olofsson B. , Korpelainen E. , Pepper MS , et al. Vascular endothelial growth factor B (VEGF-B) binds to VEGF receptor-1 and regulates plasminogen activator activity in endothelial cells. Proc Natl Acad Sci U S A. 1998;95(20):11709-11714.

23.

Artini PG , Monti M. , Matteucci C. , Valentino V. , Cristello F. , Genazzani AR Vascular endothelial growth factor and basic fibroblast growth factor in polycystic ovary syndrome during controlled ovarian hyperstimulation. Gynecol Endocrinol. 2006;22(8): 465-470.

24.

Artini PG , Ruggiero M. , Parisen Toldin MR , et al. Vascular endothelial growth factor and its soluble receptor in patients with polycystic ovary syndrome undergoing IVF. Hum Fertil (Camb). 2009;12(1):40-44.

25.

Agrawal R. , Sladkevicius P. , Engmann L. , et al. Serum vascular endothelial growth factor concentrations and ovarian stromal blood flow are increased in women with polycystic ovaries . Hum Reprod. 1998;13(3):651-655.

26.

Amin AF , Abd el-Aal DE , Darwish AM , Meki AR Evaluation of the impact of laparoscopic ovarian drilling on Doppler indices of ovarian stromal blood flow, serum vascular endothelial growth factor, and insulin-like growth factor-1 in women with polycystic ovarian symdrome . Fertil Steril. 2003;79(4):938-941.

27.

Friedman CI , Seifer DB , Kennard EA , Arbogast L. , Alak B. , Danforth DR Elevated level of follicular fluid vascular endothelial growth factor is a marker of diminished pregnancy potential. Fertil Steril. 1998 ;70(5):836-839.

28.

Asimakopoulos B. , Nikolettos N. , Papachristou DN , Simopoulou M. , Al- Hasani S. , Diedrich K. Follicular fluid levels of endothelial growth factor and leptin are associated with pregnancy outcome of normal women participating in intracytoplasmic sperm injection cycles. Physiol Res. 2005;54(3):263-270.

29.

Ocal P. , Aydin S. , Cepni I. , et al. Follicular fluid concentrations of vascular endothelial growth factor, inhibin A and inhibin B in IVF cycles: are they markers for ovarian response and pregnancy outcome? Eur J Obstet Gynecol Reprod Biol. 2004;115(2):194-199.

30.

Lee A. , Christenson LK , Stouffer RL , Burry KA , Patton PE Vascular endothelial growth factor levels in serum and follicular fluid of patients undergoing in vitro fertilization. Fertil Steril . 1997;68(2):305-311.

31.

Thessaloniki ESHRE / ASRM-Sponsored PCOS Consensus Workshop Group. Consensus on infertility treatment related to polycystic ovary syndrome. Fertil Steril. 2008;89(3):505-522.

32.

Malizia BA , Wook YS , Penzias AS , Usheva A. The human ovarian follicular fluid level of interleukin-8 is associated with follicular size and patient age. Fertil Steril. 2010;93(2):537-543.

33.

Practice Committee of the Society for Assisted Reproductive Technology ; Practice Committee of the American Society for Reproductive Medicine. Guidelines on number of embryos transferred . Fertil Steril. 2006;86(5 suppl 1):S51-S52.

34.

Ravindranath N. , Little-Ihrig L. , Phillips HS , Ferrara N. , Zeleznik AJ Vascular endothelial growth factor messenger ribonucleic acid expression in the primate ovary. Endocrinology . 1992;131(1):254-260.

35.

Garcia de la Torre N. , Rubio MA , Bordiu E. , et al. Effects of weight loss after bariatric surgery for morbid obesity on vascular endothelial growth factor-A, adipocytokines, and insulin. J Clin Endocrinol Metab. 2008 ;93(11):4276-4281.

36.

Friedman CI , Danforth DR , Herbosa-Encarnacion C. , Arbogast L. , Alak BM , Seifer DB Follicular fluid vascular endothelial growth factor concentrations are elevated in women of advanced reproductive age undergoing ovulation induction. Fertil Steril. 1997;68(4):607-612.

37.

Kim KH , Oh DS , Jeong JH , Shin BS , Joo BS , Lee KS Follicular blood flow is a better predictor of the outcome of in vitro fertilization-embryo transfer than follicular fluid vascular endothelial growth factor and nitric oxide concentrations. Fertil Steril. 2004;82(3):586-592.

38.

Attar E. , Genc S. , Bulgurcuoglu S. , Topuz S. , Serdaroglu H. Increased concentration of vascular endothelial growth factor in the follicular fluid of patients with endometriosis does not affect the outcome of in vitro fertilization-embryo transfer. Fertil Steril. 2003;80(6):1518-1520.